Enhanced AC133-Specific CAR T Cell Therapy Induces Durable Remissions in Mice with Metastatic Small Cell Lung Cancer

AC133+ cancer stem cells and PD-L1+CD73+ myeloid cells were detectable in primary human small cell lung cancer tissues, suggesting that patients may benefit from the triple-immunotherapy.